Cytosolic carbonic anhydrase activity in chronic myeloid disorders with different clinical phenotype.
Carbonic anhydrase family (CAs) plays an important role in the extracellular acidification and several studies suggest a possible involvement of such enzymes in the increased tumor progression due to the acidic extracellular pH. We measured the activities of carbonic anhydrase I and II isoforms in a group of patients affected by four specific chronic haematological diseases, sharing a common origin but characterized by a different neoplastic evolution: agnogenic myeloid metaplasia (AMM), essential thrombocythemia (ET), chronic myeloid leukemia (CML) and polycythemia vera (PV) in order to understand the correlation between CAs activities and neoplastic outcome. In comparison to controls, our data demonstrate an increase of CAI and CAII activities in all our patients with a specific increase of the CAI activity in the group of the diseases with major malignancy (CML and AMM). These results suggest a possible role of such isozymes in the progression of the myeloid disorders and CAs specific inhibitors should be useful in slowing the progression of the disease.
Department of Pediatrics, Faculty of Medicine, University Magna Graecia of Catanzaro, Ospedale Civile A. Pugliese, Viale Pio X, 88100, Italy.
Giuseppe
G
Bonapace
Francesco
F
Iuliano
Stefano
S
Molica
Antonio
A
Peta
Pietro
P
Strisciuglio
D002256:Carbonic Anhydrases / Q000378:metabolism*; D003600:Cytosol / Q000201:enzymology*; D006801:Humans; D009196:Myeloproliferative Disorders / Q000201:enzymology* / Q000473:pathology; D010641:Phenotype
D002256:Carbonic Anhydrases